Search Results

Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.

• Authors : Zeevat F; Department of Health Sciences, University of Groningen, University Medical Centre, Groningen, The Netherlands. Electronic address: .; Crépey P

Subjects: Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*economics ; Influenza Vaccines/Influenza Vaccines/Influenza Vaccines/*immunology ; Influenza, Human/Influenza, Human/Influenza, Human/*prevention & control

• Source: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 3-10.Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print Cited Medium: Internet ISSN: 1524-4733

Record details

The effect of moral appeals on influenza vaccination uptake and support for a vaccination mandate among health care workers.

• Authors : Mulder, Laetitia B.¹ (AUTHOR) ; Lokate, Mariëtte² (AUTHOR)

Subjects: *VACCINATION policies; *INFLUENZA prevention; *CROSS infection preventionNETHERLANDS; UNITED Kingdom; UNITED States

• Source: Social Science & Medicine. Nov2022, Vol. 312, pN.PAG-N.PAG. 1p.

Record details

Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment.

• Source: Vaccine Weekly. 2009, pages. 82

Record details

The Dutch influenza vaccination policy and medication use, outpatient visits, hospitalization and mortality at age 65.

• Authors : Ourti, Tom Van^1,2 ; Bouckaert, Nicolas^3,4

Subjects: *INFLUENZA prevention; *MORTALITY prevention; *PNEUMONIA-related mortalityNETHERLANDS

• Source: European Journal of Public Health. Apr2020, Vol. 30 Issue 2, p275-280. 6p.

Record details

Economic evaluation of influenza vaccination. Assessment for The Netherlands.

• Authors : Postma, M J¹ (AUTHOR); Bos, J M (AUTHOR); van Gennep, M (AUTHOR)

Subjects: *COST effectiveness; *QUESTIONNAIRES; *ECONOMICSNETHERLANDS

• Source: PharmacoEconomics. 1999, Vol. 16 Issue 1, p33-40. 8p.

Record details

Years of Life Lost Due to Influenza-Attributable Mortality in Older Adults in the Netherlands: A Competing-Risks Approach.

• Authors : McDonald, Scott A¹ ; Wijhe, Maarten van¹; Asten, Liselotte van¹

Subjects: *INFLUENZA prevention; *MORTALITY; *CONFIDENCE intervalsNETHERLANDS

• Source: American Journal of Epidemiology. Aug2018, Vol. 187 Issue 8, p1791-1798. 8p.

Record details

Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment.

• Source: Marketwire. 2009.

Record details

Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment.

• Source: Internet Wire. 2009.

Record details

Johnson & Johnson and Crucell Announce Strategic Collaboration to Develop Innovative Products, Including Therapies for Influenza Prevention and Treatment.

• Source: PR Newswire. 2009.

Record details

[Practice guideline 'Influenza prevention in nursing homes and care homes', issued by the Dutch Society of Nursing Home Specialists; division of tasks between nursing home specialist, general practitioner and company doctor].

• Authors : Cools HJ; van Essen GA ...

Subjects: Practice Guidelines as Topic*; Acetamides/Acetamides/Acetamides/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

• Source: Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2005 Jan 15; Vol. 149 (3), pp. 119-24; discussion 116-8.Publisher: Vereniging NTvG Country of Publication: Netherlands NLM ID: 0400770 Publication Model: Print Cited Medium:

Record details